SCYNEXIS, Inc. (SCYX) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- SCYNEXIS, Inc. SCYX 3.67 −6.14%
- Shuttle Pharmaceuticals Holdings, Inc. SHPH 5.08 −8.80%
SCYNEXIS, Inc. and Shuttle Pharmaceuticals Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $38.9M against $26.5M — 1.5× the size. SCYNEXIS, Inc. has negative trailing earnings, so its P/E is not meaningful; Shuttle Pharmaceuticals Holdings, Inc. trades at 0.2×. Shuttle Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (−36.7% vs −110.7%). Across the 13 metrics below, Shuttle Pharmaceuticals Holdings, Inc. leads on 8 and SCYNEXIS, Inc. on 5.
Valuation
Profitability
| Metric | SCYX | SHPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 53.94% |
| Operating margin | (109.90%) | 0.00% | 0.00% |
| Net margin | (49.74%) | 0.00% | 0.00% |
| Free cash flow margin | (64.67%) | 0.00% | 0.00% |
| Return on equity | (18.38%) | (90.05%) | (0.40%) |
| Return on assets | (15.09%) | (72.47%) | (3.32%) |
| Return on invested capital | (110.72%) | (36.73%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack